Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ERAS | RLI |
|---|---|---|
| Price | $14.72 | $56.08 |
| Change today | ▼ 0.14% | ▲ 0.25% |
| Market cap | $5.15B | $5.15B |
| Return, 3 months | -19.8% | -9.5% |
| Return, year to date | +295.7% | -8.0% |
| Return, 1 year | +531.8% | -5.0% |
| P/E (TTM) | -15.5 | 11.8 |
| P/B | 14.2 | 2.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 1.18% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 42 | 33 |
| 30-day volatility | 58.4% | 19.5% |
| Max drawdown, 1 year | -59.5% | -27.9% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
